• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Patient-Device Incompatibility (2682); Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Autoimmune Disorder (1732); Autoimmune Reaction (1733)
Event Type  Injury  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of autoimmune disorder ("autoimmune issues") in a female patient who had essure inserted.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced autoimmune disorder (seriousness criteria medically significant and intervention required).Essure was removed.At the time of the report, the autoimmune disorder had not resolved.The reporter considered autoimmune disorder to be related to essure.Concerning the injuries reported in this case, the following one/ones were reported via social media; autoimmune disease.Incident: no lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
The spontaneous case was reported by a lawyer and describes the occurrence of autoimmune disorder ("autoimmune issues") in a female patient who had essure inserted.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced autoimmune disorder (seriousness criteria medically significant and intervention required).Essure was removed.At the time of the report, the autoimmune disorder had not resolved.The reporter considered autoimmune disorder to be related to essure.Concerning the injuries reported in this case, the following one/ones were reported via social media; autoimmune disease.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 30-oct-2018: quality safety evaluation of ptc.Incident: no lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
This spontaneous case was reported by a lawyer and describes the occurrence of autoimmune disorder ('autoimmune issues') in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patients had essure inserted.On an unknown date, the patients experienced autoimmune disorder (seriousness criteria medically significant and intervention required) and allergy to metals ("nickel allergy").Essure was removed.At the time of the report, the autoimmune disorder had not resolved and the allergy to metals outcome was unknown.The reporter considered allergy to metals and autoimmune disorder to be related to essure.Concerning the injuries reported in this case, the following one/ones were reported via social media; autoimmune disease.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 17-dec-2019: social media received.Event : nickel allergy were added.Based on the available information, a review of our complaint records and other relevant data will be conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This spontaneous case was reported by a lawyer and describes the occurrence of autoimmune disorder ('autoimmune issues') in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patients had essure inserted.On an unknown date, the patients experienced autoimmune disorder (seriousness criteria medically significant and intervention required) and allergy to metals ("nickel allergy").Essure was removed.At the time of the report, the autoimmune disorder had not resolved and the allergy to metals outcome was unknown.The reporter considered allergy to metals and autoimmune disorder to be related to essure.Concerning the injuries reported in this case, the following one/ones were reported via social media; autoimmune disease.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 23-jul-2020: quality safety evaluation of ptc.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key7640606
MDR Text Key112429082
Report Number2951250-2018-02829
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup,Followup,Followup
Report Date 07/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/07/2018
Initial Date FDA Received06/27/2018
Supplement Dates Manufacturer Received10/30/2018
12/17/2019
07/23/2020
Supplement Dates FDA Received10/30/2018
01/07/2020
07/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-